3.145.94.251
dgid:
enl:
npi:0

-Advertisement-

-Advertisement-

Home The Ophthalmic Project: What to expect at AAO 2023 Annual Meeting

Conference Roundup

The Ophthalmic Project: What to expect at AAO 2023 Annual Meeting

Read More

By rd360stg

Phase 4 data demonstrates Cequa’s sustained efficacy in dry eye disease

By rd360stg

Optogenetic therapy shows promise in treating Stargardt disease: STARLIGHT Trial

By rd360stg

Gene therapy RGX-314 shows promise in the treatment of nAMD

By rd360stg

Real-world study confirms faricimab’s efficacy in patients with nAMD

-Advertisement-

-Advertisement-

-Advertisement-

By rd360stg

SB15 biosimilar shows similar efficacy to reference aflibercept up to 56 weeks in nAMD

By rd360stg

New research sheds light on prevalence of inherited retinal diseases in the US

By rd360stg

Complications in gene therapy for inherited retinal diseases highlighted at ASRS 2023

By rd360stg

Intravitreal avacincaptad pegol demonstrates promising results for geographic atrophy

-Advertisement-

-Advertisement-

-Advertisement-

By rd360stg

Study suggests monthly pegcetacoplan outperforms avacincaptad pegol in reducing GA lesion growth

By rd360stg

Are prior authorizations for anti-VEGF intravitreal injections needed?

By rd360stg

Aflibercept 8 mg offers superior benefits for nAMD over aflibercept 2 mg

By rd360stg

Glaukos launches iDetective campaign to aid early detection of keratoconus

-Advertisement-

-Advertisement-

Videos

The Ophthalmic Project: What to expect at AAO 2023 Annual Meeting

31 Oct, 2023

Mark Dlugoss: The American Academy of Ophthalmology’s annual meeting is...

-Advertisement-

-Advertisement-

Contact Info

Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809

+908-505-8899

[email protected]

Social Links

© 2024 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved

-Advertisement-

-Advertisement-